UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation

Alimentary pharmacology & therapeutics, 2014-10, Vol.40 (7), p.771-779

2014

Volltextzugriff (PDF)

Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies

Alimentary pharmacology & therapeutics, 2009-02, Vol.29 (3), p.329-341

2009

Volltextzugriff (PDF)

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.745-767

2012

Volltextzugriff (PDF)

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (4), p.426-437

2014

Volltextzugriff (PDF)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1161-1168

2014

Volltextzugriff (PDF)

Randomised clinical trials: linaclotide phase 3 studies in IBS‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints

Alimentary pharmacology & therapeutics, 2013-01, Vol.37 (1), p.49-61

2013

Volltextzugriff (PDF)

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2012-03, Vol.35 (5), p.587-599

2012

Volltextzugriff (PDF)

Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects

Alimentary pharmacology & therapeutics, 2008-01, Vol.27 (2), p.186-196

2008

Volltextzugriff (PDF)

Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (10), p.1275-1291

2010

Volltextzugriff (PDF)

Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale

Alimentary pharmacology & therapeutics, 2009-12, Vol.30 (11‐12), p.1159-1170

2009

Volltextzugriff (PDF)

Review article: current and emerging therapies for functional dyspepsia

Alimentary pharmacology & therapeutics, 2006-08, Vol.24 (3), p.475-492

2006

Volltextzugriff (PDF)

Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux disease

Alimentary pharmacology & therapeutics, 2009-06, Vol.29 (12), p.1261-1272

2009

Volltextzugriff (PDF)

Factors Associated with Symptom Severity in Women Presenting with Fecal Incontinence

Diseases of the colon & rectum, 2013-01, Vol.56 (1), p.97-102

2013

Volltextzugriff (PDF)

The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2008-03, Vol.27 (6), p.473-482

2008

Volltextzugriff (PDF)

Editorial: recurrence of Helicobacter pylori infection—still the same after all these years

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.131-132

2018

Volltextzugriff (PDF)

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1192-1202

2010

Volltextzugriff (PDF)

Review article: irritable bowel syndrome: an evidence-based approach to diagnosis

Alimentary pharmacology & therapeutics, 2004-06, Vol.19 (12), p.1235-1245

2004

Volltextzugriff (PDF)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (10), p.1319-1328

2017

Volltextzugriff (PDF)

Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2007-08, Vol.26 (3), p.443-452

2007

Volltextzugriff (PDF)

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2016-11, Vol.44 (10), p.1114-1122

2016

Volltextzugriff (PDF)

Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers

Alimentary pharmacology & therapeutics, 2008-11, Vol.28 (10), p.1249-1258

2008

Volltextzugriff (PDF)

Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis

Alimentary pharmacology & therapeutics, 2002-08, Vol.16 (8), p.1491-1501

2002

Volltextzugriff (PDF)

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

Clinical gastroenterology and hepatology, 2018-10, Vol.16 (10), p.1673-1676

2018

Volltextzugriff (PDF)

Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation

Alimentary pharmacology & therapeutics, 2005-12, Vol.22 (11‐12), p.1047-1060

2005

Volltextzugriff (PDF)

The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology

Alimentary pharmacology & therapeutics, 2010-01, Vol.31 (2), p.313-322

2010

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(222)

Publikationsform

Artikel
(324)
Tagungsberichte
(1)

Sprache

Englisch
(324)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Life Sciences & Biomedicine
(185)
Humans
(161)
Gastroenterology & Hepatology
(135)
Biological And Medical Sciences
(110)
Male
(108)
Female
(107)
Medical Sciences
(94)
Middle Aged
(89)
Adult
(86)
Gastroenterology. Liver. Pancreas. Abdomen
(51)
Gastroenterology
(49)
Aged
(43)
Digestive System
(37)
Pharmacology & Pharmacy
(36)
Animals
(35)
Other Diseases. Semiology
(35)
Helicobacter Pylori
(34)
Pharmacology. Drug Treatments
(33)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation

Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

Randomised clinical trials: linaclotide phase 3 studies in IBS‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints

Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation

Comparison of gastric emptying of a nondigestible capsule to a radio‐labelled meal in healthy and gastroparetic subjects

Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials

Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale

Review article: current and emerging therapies for functional dyspepsia

Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux disease

Factors Associated with Symptom Severity in Women Presenting with Fecal Incontinence

The influence of co‐morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro‐oesophageal reflux disease

Editorial: recurrence of Helicobacter pylori infection—still the same after all these years

Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice

Review article: irritable bowel syndrome: an evidence-based approach to diagnosis

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies

Oesophageal hypersensitivity is associated with features of psychiatric disorders and the irritable bowel syndrome

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation

Changing perceptions and practices regarding aspirin, nonsteroidal anti‐inflammatory drugs, and cyclooxygenase‐2 selective nonsteroidal anti‐inflammatory drugs among US primary care providers

Reappraisal of non‐invasive management strategies for uninvestigated dyspepsia: a cost‐minimization analysis

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients

Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation

The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology

Suchergebnisse filtern